メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
富山大学 ホーム
日本語
English
ホーム
プロファイル
研究部門
プロジェクト
研究成果
データセット
受賞
活動
コース
専門知識、名前、または所属機関で検索
透析部
富山大学
医学系
概要
フィンガープリント
ネットワーク
プロファイル
(2)
研究成果
(18)
フィンガープリント
透析部が活動している研究トピックを掘り下げます。これらのトピックラベルは、この組織のメンバーの研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Keyphrases
Chronic Kidney Disease
100%
Nephrotic Syndrome
63%
Renal Disease
51%
Tolvaptan
48%
Aquaporin-2 (AQP2)
47%
Hemodialysis
45%
Microalbuminuria
43%
Cyclic Adenosine Monophosphate (cAMP)
37%
Prognostic Impact
35%
Hemodialysis Initiation
32%
Glomerulonephritis
32%
Essential Hypertension
32%
IgA Nephropathy (IgAN)
31%
Collecting Duct
29%
Steroid Therapy
29%
Estimated Glomerular Filtration Rate
28%
Congestive Heart Failure
25%
End-stage Renal Disease
25%
Older Men
25%
Japan
23%
Clinical Features
21%
Sectional Analysis
21%
Young Adult Patients
21%
Histopathological Features
21%
Renal Biopsy Registry
21%
Pediatric
21%
Sham
21%
Structural Properties
21%
Rat Model
21%
Uremic Toxins
21%
Intra-abdominal Bleeding
21%
Cholesterol Crystal Embolism
21%
Cryofibrinogen
21%
Membranous Nephropathy
21%
Sclerosing mucoepidermoid Carcinoma with Eosinophilia
21%
Kimura Disease
21%
Renal Vascular
21%
Older Adults
21%
Mucoepidermoid Carcinoma
21%
Vascular Endothelial Growth Factor Inhibitors
21%
Type 2 Diabetes Mellitus (T2DM)
21%
Advanced Gastric Cancer
21%
Older Patients
21%
Parotid Gland
21%
Peritoneal Dialysis
21%
Gemella Morbillorum
21%
Crescentic Glomerulonephritis
21%
IgA2
21%
Mantle Cell Lymphoma
21%
Arginine Vasopressin
21%
Dopamine
21%
Infective Endocarditis
21%
5-hydroxytryptamine
21%
Remote Dielectric Sensing
21%
Focal Segmental Glomerulosclerosis
21%
Intravitreal Injection
21%
Goreisan
21%
Renal Biopsy
17%
Urine Volume
16%
Renal Impairment
16%
Glomerular Filtration Rate
16%
AST-120
16%
Filtration Capacity
16%
Flow Pressure
16%
Glomerular Filtration
16%
Heart Failure
14%
Glomerulus
14%
Remission
13%
Non-dipper
13%
Nondipper
13%
Kampo
13%
Home Care
13%
Aquaresis
12%
Systolic Blood Pressure
12%
Hemodialysis Patients
11%
Refractoriness
11%
Pathological Findings
11%
Blood Pressure
11%
Kidney
10%
Familial Clustering
10%
Malignant Hypertension
10%
Bladder Pheochromocytoma
10%
Vascular Wall
10%
Creatinine Index
10%
Takayasu Arteritis
10%
Nocturnal Blood Pressure
10%
Medical Expenses
10%
Renal Tubular Acidosis
10%
Acute Hyperkalemia
10%
Growth Differentiation factor-15 (GDF-15)
10%
Fanconi Syndrome
10%
Non-dipper Pattern
10%
Native Kidney
10%
Metabolic Alkalosis
10%
Dielectric Bodies
10%
Pyloric Stenosis
10%
Neck Mass
10%
Nephrectomized
10%
Body Fluid Distribution
10%
Vascular Lumen
10%
Medicine and Dentistry
Chronic Kidney Disease
94%
Hemodialysis
73%
Nephrotic Syndrome
66%
Aquaporin 2
50%
Tolvaptan
50%
Glomerular Filtration Rate
48%
Glomerulonephritis
43%
Renal Biopsy
40%
Cyclic AMP
39%
Nephropathy
32%
Immunoglobulin A Nephropathy
31%
Collecting Duct
30%
End Stage Renal Disease
29%
Steroid Therapy
29%
Microalbuminuria
24%
Patient with Congestive Heart Failure
23%
Glomerulus Filtration
22%
Argipressin
21%
Cross Sectional Study
21%
Macroalbuminuria
21%
Angiolymphoid Hyperplasia with Eosinophilia
21%
Membranous Glomerulonephritis
21%
Uremic Toxin
21%
Pediatrics
21%
Mucoepidermoid Carcinoma
21%
Eosinophilia
21%
Vasculotropin Inhibitor
21%
Gemella morbillorum
21%
Essential Hypertension
21%
Abdominal Bleeding
21%
Parotid Gland
21%
Observational Study
21%
Peritoneal Dialysis
21%
Embolization
21%
Mantle Cell Lymphoma
21%
Maturity Onset Diabetes of the Young
21%
Infective Endocarditis
21%
Serotonin
21%
Intravitreal Administration
21%
Focal Segmental Glomerulosclerosis
21%
Congestive Heart Failure
21%
Adolescence
21%
Abdominal Cancer
21%
Creatinine
18%
Urinary System
17%
Combination Therapy
15%
Interlobular Arteries
14%
Resistance Vessel
14%
Kampo
14%
Glomerulus
13%
Cancer
12%
Kidney Function
12%
Chemotherapy
11%
Primary Hyperaldosteronism
10%
Malignant Hypertension
10%
Takayasu's Arteritis
10%
Fanconi Syndrome
10%
Renal Tubular Acidosis
10%
Growth Differentiation Factor 15
10%
Xanthine Oxidase
10%
Kidney Transplantation
10%
Metabolic Alkalosis
10%
Neck Mass
10%
Geriatrics
10%
Lipid Storage
10%
Liquid Chromatography-Mass Spectrometry
10%
Glomerular Capillary
10%
Aflibercept
10%
Ascites
10%
Clear Cell Renal Cell Carcinoma
10%
Checklist
10%
Acute Kidney Injury
10%
Pembrolizumab
10%
Infection
10%
Sodium Zirconium Cyclosilicate
10%
Hyperkalemia
10%
Aortic Insufficiency
10%
Elderly Patient
10%
Pylorus Stenosis
10%
Bladder
10%
Interstitial Nephritis
10%
Pheochromocytoma
10%
Blood Pressure
10%
Proteinuria
9%
Bleeding
9%
Case Presentation
9%
Disease
9%
Metastatic Carcinoma
9%
Differential Diagnosis
9%
Computer Assisted Tomography
7%
Biological Marker
7%
Bartter Syndrome
7%
Brain Natriuretic Peptide
7%
Vascularity
7%
Nephrectomy
7%
Vascular Resistance
7%
Kidney Vascular Resistance
7%
Adsorbent
7%
Protein Diet
7%
Omentum
7%
Pharmacology, Toxicology and Pharmaceutical Science
Tolvaptan
59%
Congestive Heart Failure
56%
Aquaporin 2
47%
Chronic Kidney Failure
37%
Hemodialysis
32%
Nephrotic Syndrome
32%
Cyclic AMP
26%
Kampo Medicine (Drug)
24%
Glomerulonephritis
21%
Vasculotropin Inhibitor
21%
Abdominal Cancer
21%
Argipressin
21%
Macroalbuminuria
21%
End Stage Renal Disease
21%
Intravitreal Administration
21%
Focal Glomerulosclerosis
21%
Non Insulin Dependent Diabetes Mellitus
21%
Observational Study
21%
Combination Therapy
17%
Remission
13%
Hyperkalemia
10%
Sodium Zirconium Cyclosilicate
10%
Growth Differentiation Factor 15
10%
Kidney Disease
10%
Ascites
10%
Aflibercept
10%
Frailty
10%
Xanthine Oxidase
10%
Pheochromocytoma
10%
Prevalence
7%
Diuretic Therapy
7%
Vasopressin
6%
Brain Natriuretic Peptide
6%
Oxaliplatin
5%
Chemotherapy
5%
Systemic Administration
5%
Hematuria
5%
Immobility
5%
Rare Disease
5%
Adenocarcinoma
5%
Oteracil Potassium
5%
Fibrinogen
5%
Agents Acting on the Eye
5%
Kidney Injury
5%
Hypoalbuminemia
5%
Electron Microscopy
5%
Disease
5%
Proteinuria
5%
Leg Edema
5%
Membranoproliferative Glomerulonephritis
5%
Fibronectin
5%
Tegafur
5%
Gimeracil
5%
Prospective Study
5%